Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Bone and Mineral Metabolism
Published in: Journal of Bone and Mineral Metabolism 4/2009

01-07-2009 | Case Report

Atypical thyrotropin-secreting pituitary microadenoma revealed by severe osteoporosis in a young man

Authors: Alexis de Rougemont, Marie-Gabrielle Mourot, Jean-Paul Riou

Published in: Journal of Bone and Mineral Metabolism | Issue 4/2009

Login to get access

Abstract

For 10 years, a young man was followed for a severe osteoporosis associated with a considerable reduction in height and a massive weight loss. The constant increase of signs of tissue impregnation with thyroid hormones and the molar ratios of α-TSH suggested an inappropriate secretion of thyrotropin. Magnetic resonance imaging finally revealed a thyrotropic microadenoma of the pituitary gland. This case gives some new additional information on thyrotropin-induced osteoporosis. To our knowledge such a case has never been reported in the literature.
Literature
1.
Zuniga S, Mendoza V, Espinoza IF, Zarate A, Mason M, Mercado M (1997) A plurihormonal TSH-secreting pituitary microadenoma: report of a case with an atypical clinical presentation and transient response to bromocriptine therapy. Endocr Pathol 8(1):81–86PubMedCrossRef
2.
Gurnell M, Rajanayagam O, Barbar I, Jones MK, Chatterjee VK (1998) Reversible pituitary enlargement in the syndrome of resistance to thyroid hormone. Thyroid 8(8):679–682PubMedCrossRef
3.
Sanno N, Teramoto A, Osamura RY (2001) Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment. J Neurooncol 54(2):179–186PubMedCrossRef
4.
Bonneville JF (2000) Pituitary adenomas: value of MR imaging. J Radiol 81(9):939–942PubMed
5.
Wu YY, Chang HY, Lin JD, Chen KW, Huang YY, Jung SM (2003) Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma. J Formos Med Assoc 102(3):164–171PubMed
6.
Beck-Peccoz P, Persani L, Mantovani S, Cortelazzi D, Asteria C (1996) Thyrotropin-secreting pituitary adenomas. Metabolism 45(8 suppl 1):75–79PubMedCrossRef
7.
Boni G, Ferdeghini M, Bellina CR, Matteucci F, Castro Lopez E, Parenti G, Canapicchi R, Bianchi R (1995) [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas. Q J Nucl Med 39(4 Suppl 1):90–93PubMed
8.
Socin HV, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A (2003) The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol 148(4):433–442PubMedCrossRef
9.
Sarlis NJ, Gourgiotis L, Koch CA, Skarulis MC, Brucker-Davis F, Doppman JL, Oldfield EH, Patronas NJ (2003) MR imaging features of thyrotropin-secreting pituitary adenomas at initial presentation. AJR Am J Roentgenol 181(2):577–582PubMed
10.
Pasquini E, Faustini-Fustini M, Sciarretta V, Saggese D, Roncaroli F, Serra D, Frank G (2003) Ectopic TSH-secreting pituitary adenoma of the vomerosphenoidal junction. Eur J Endocrinol 148(2):253–257PubMedCrossRef
11.
Lindboe CF, Unsgard G, Myhr G, Scott H (1993) ACTH and TSH producing ectopic suprasellar pituitary adenoma of the hypothalamic region: case report. Clin Neuropathol 12(3):138–141PubMed
12.
Katznelson L, Alexander JM, Klibanski A (1993) Clinical review 45: clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 76(5):1089–1094PubMedCrossRef
13.
Akiyoshi F, Okamura K, Fujikawa M, Sato K, Yoshinari M, Mizokami T, Hattori K, Kuwayama A, Takahashi Y, Fujishima M (1996) Difficulty in differentiating thyrotropin secreting pituitary microadenoma from pituitary-selective thyroid hormone resistance accompanied by pituitary incidentaloma. Thyroid 6(6):619–625PubMedCrossRef
14.
Safer JD, Colan SD, Fraser LM, Wondisford FE (2001) A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma. Thyroid 11(3):281–291PubMedCrossRef
15.
Vlaeminck-Guillem V, Wemeau JL (1999) Thyroid hormone resistance syndromes: clinical aspects. Rev Med Interne 20(12):1114–1122PubMedCrossRef
16.
Glezer A, D’Alva CB, Salgado LR, Musolino NR, Serafini P, Vieira JG, Bronstein MD (2002) Pitfalls in pituitary diagnosis: peculiarities of three cases. Clin Endocrinol (Oxf) 57(1):135–139CrossRef
17.
18.
Prader A, Illig R, Uehlinger E, Stalder G (1959) Rickets following bone tumor. Helv Paediatr Acta 14:554–565PubMed
19.
Sahin M, Basoglu T, Albayrak S, Canbaz F, Yapici O (2001) Pentavalent technetium-99 m DMSA uptake in pseudofractures of osteomalacia. Clin Nucl Med 26(1):62–64PubMedCrossRef
20.
Garcia CA, Spencer RP (2002) Bone and In-111 octreotide imaging in oncogenic osteomalacia: a case report. Clin Nucl Med 27(8):582–583PubMedCrossRef
21.
22.
Abe E, Marians RC, Yu W, Wu XB, Ando T, Li Y, Iqbal J, Eldeiry L, Rajendren G, Blair HC, Davies TF, Zaidi M (2003) TSH is a negative regulator of skeletal remodeling. Cell 115(2):151–162PubMedCrossRef
23.
Simsek G, Karter Y, Aydin S, Uzun H (2003) Osteoporotic cytokines and bone metabolism on rats with induced hyperthyroidism; changes as a result of reversal to euthyroidism. Chin J Physiol 46(4):181–186PubMed
Metadata
Title
Atypical thyrotropin-secreting pituitary microadenoma revealed by severe osteoporosis in a young man
Authors
Alexis de Rougemont
Marie-Gabrielle Mourot
Jean-Paul Riou
Publication date
01-07-2009
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 4/2009
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-009-0050-1

Other articles of this Issue 4/2009

Journal of Bone and Mineral Metabolism 4/2009 Go to the issue

Original Article

Bisphosphonates are not associated with vertebral osteonecrosis

Original Article

Bone mass in schoolchildren in Brazil: the effect of racial miscegenation, pubertal stage, and socioeconomic differences

Original Article

Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid

Original Article

Bone quantity and quality in Brazilian female schoolchildren and adolescents

Announcement

Journal of Bone and Mineral Metabolism Best Paper Award 2008

Original Article

Relationship of body mass index with main limb fragility fractures in postmenopausal women
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits